iRhythm Holdings Q1 Revenue Jumps 25.7% to $199.39M, Loss Narrows Significantly
IRTC sits 20% above its 52-week low of $105 on elevated volume (1.8× avg).
Summary
iRhythm Holdings reported strong first-quarter 2026 results, with revenue increasing 25.7% year-over-year to $199.39 million. The company also significantly narrowed its net loss, with diluted EPS improving to ($0.43) from ($0.97) in the prior year quarter. This positive performance was driven by higher volume of iRhythm Services, increased enterprise account usage, and improved market access and contracting. The improved financial metrics suggest operational efficiencies and progress towards profitability, which is a material development for the company following its 2025 performance that included a reduced net loss. Traders will be watching for continued revenue growth and further progress in reducing losses in upcoming quarters, especially given the ongoing legal and regulatory challenges mentioned in the last 10-K.
At the time of this announcement, IRTC was trading at $126.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $105.00 to $212.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.